(15055031), A. E., (15055034), L. S., (15055037), S. I. V., (15055040), L. A. H., (14947288), C. A. L., (15055043), V. F., . . . (14947294), C. L. (2025). Supplementary Table S6 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial.
Chicago Style (17th ed.) Citation(15055031), Andrés Elía, et al. Supplementary Table S6 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial. 2025.
MLA (9th ed.) Citation(15055031), Andrés Elía, et al. Supplementary Table S6 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial. 2025.